OBD was spun out from Oxford University in June 2007 with the aim of translating fundamental scientific advances into a commercialised platform technology and a new generation of biomarkers for cancer and other diseases.

The Company started its operations from its first Reference Laboratory in the University Science Park at Begbroke, Oxford. Today, Company Offices are based at 26 Beaumont Street, Oxford, in the very centre of the historical University city. Oxford Biodynamics’ state-of-the-art Reference Laboratory as well as Quality Control and Quality Assurance facilities are based at Oxford Business Park North, Garsington Road, Oxford.

Oxford BioDynamics’ leadership team has extensive biotechnology, health and commercial experience and as such works as a dynamic unit committed to researching epigenetics and producing reliable methods of screening, diagnosis and monitoring of diseases with aberrant gene expression.